Mazor Robotics Receives FDA Clearance For Mazor X Align Software

(RTTNews) - Mazor Robotics Ltd. (MZOR), an Israeli developer of bone mounted surgical robotic guidance systems, Wednesday said it has received FDA clearance for its Mazor X Align software.

In pre-market activity on Nasdaq, Mazor Robotics shares were gaining 3.2 percent to $29.55.

In a statement, the company noted that Mazor X Align is designed to assist surgeons in planning spinal deformity correction and spinal alignment for procedures performed with the Mazor X Surgical Assurance Platform.

The new software will be demonstrated during exhibit hours at the 2017 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Los Angeles, CA, April 22-26.

According to Ori Hadomi, CEO of Mazor Robotics, "Mazor X Align is the product of Mazor's development program and represents our innovative pipeline and visionary team experience. We are dedicated to pushing the envelope bringing to the market advanced products and applications in order to benefit an increasing number of patients suffering from difficult conditions and supporting the medical professionals serving them."

Mazor X Align will be released to a selection of Mazor X customers in early May. This early release will be followed by a widespread release during the second half of 2017.